Offering the best quotes for your research!

New and used scientific instruments

🚚 Shipping Worldwide 🌎

📞+31 (0) 73 7114717

✉️ info@questpair.com

Loading...

OR


Filters

Do you have items to sell? Post them on QuestPair and reach thousands of potential buyers!

Post New Item

Immucor: Pioneering Transfusion and Transplant Diagnostics

Introduction

Immucor, established in 1982, has been at the forefront of transfusion and transplantation diagnostics for over three decades. Founded by Richard A. Flynt, the company has expanded its reach globally through strategic mergers and acquisitions, including the notable acquisition of the diagnostics company, Gamma Biologicals, in 2006. Immucor's trajectory has seen it evolve from a small startup to a

 (more)prominent entity in the field of immunohematology, with a focus on developing innovative blood banking solutions. #### Core Product Offerings Immucor's product portfolio is diverse, encompassing a comprehensive range of reagents, instruments, and software for blood typing and screening. The company is particularly renowned for its automated immunoassay platforms, such as the NEO® Series, which have set industry standards for high-throughput blood testing. Their product lines also extend to advanced molecular diagnostics, offering precise genotyping and antibody detection to support complex immunological assessments. #### Industries Served The primary industries served by Immucor include healthcare, specifically clinical laboratories, blood banks, and hospital transfusion services. The company's diagnostic solutions are instrumental in ensuring safe blood transfusions and organ transplants, with applications ranging from donor-recipient compatibility testing to disease screening and patient monitoring. #### Reputation and Notable Technologies Immucor is highly regarded for its commitment to advancing transfusion medicine and transplantation diagnostics. The brand is synonymous with quality and innovation, having introduced a series of patented technologies that have revolutionised the field. Notably, Immucor's Echo® Lumena™, a high-definition immunohematology instrument, has been acknowledged for its groundbreaking precision and efficiency. The company is also credited with launching the first FDA-approved molecular immunohematology reagent, reinforcing its market leadership and dedication to cutting-edge research. #### Conclusion In summary, Immucor remains a vital contributor to the diagnostics industry, consistently delivering solutions that enhance the safety and efficacy of blood transfusions and organ transplants. Its enduring commitment to innovation and excellence cements its status as a key player in shaping the future of transfusion and transplantation diagnostics.
Galileo ECHO
Products: 1
Pages: 1

Customer Service

Here to help you with: Product Inquiries, Shipping & Support, Technical Support, Business Inquiries and Press.

We are available to assist you Mon-Fri, 10am - 5pm CET.

+31 (0) 73 7114717
info@questpair.com